249 related articles for article (PubMed ID: 27063274)
1. Current Pharmacologic Therapy for Nonalcoholic Fatty Liver Disease.
Ganesh S; Rustgi VK
Clin Liver Dis; 2016 May; 20(2):351-64. PubMed ID: 27063274
[TBL] [Abstract][Full Text] [Related]
2. Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
Takahashi Y; Sugimoto K; Inui H; Fukusato T
World J Gastroenterol; 2015 Apr; 21(13):3777-85. PubMed ID: 25852263
[TBL] [Abstract][Full Text] [Related]
3. Current and emerging therapies in nonalcoholic fatty liver disease.
Kashi MR; Torres DM; Harrison SA
Semin Liver Dis; 2008 Nov; 28(4):396-406. PubMed ID: 18956296
[TBL] [Abstract][Full Text] [Related]
4. Medical and Surgical Treatment Options for Nonalcoholic Steatohepatitis.
Corey KE; Rinella ME
Dig Dis Sci; 2016 May; 61(5):1387-97. PubMed ID: 26942734
[TBL] [Abstract][Full Text] [Related]
5. Pharmacotherapy of nonalcoholic steatohepatitis: Reflections on the existing evidence.
Tang JT; Mao YM
J Dig Dis; 2017 Nov; 18(11):607-617. PubMed ID: 29106066
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic therapy of non-alcoholic steatohepatitis.
Ratziu V; Zelber-Sagi S
Clin Liver Dis; 2009 Nov; 13(4):667-88. PubMed ID: 19818312
[TBL] [Abstract][Full Text] [Related]
7. Review article: Drug therapy for non-alcoholic fatty liver disease.
Comar KM; Sterling RK
Aliment Pharmacol Ther; 2006 Jan; 23(2):207-15. PubMed ID: 16393299
[TBL] [Abstract][Full Text] [Related]
8. Treatment Strategies for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.
Golabi P; Bush H; Younossi ZM
Clin Liver Dis; 2017 Nov; 21(4):739-753. PubMed ID: 28987260
[TBL] [Abstract][Full Text] [Related]
9. Nonalcoholic fatty liver disease.
Paredes AH; Torres DM; Harrison SA
Clin Liver Dis; 2012 May; 16(2):397-419. PubMed ID: 22541706
[TBL] [Abstract][Full Text] [Related]
10. Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment.
Bugianesi E; Marzocchi R; Villanova N; Marchesini G
Best Pract Res Clin Gastroenterol; 2004 Dec; 18(6):1105-16. PubMed ID: 15561641
[TBL] [Abstract][Full Text] [Related]
11. State of the art: treatment of nonalcoholic steatohepatitis.
Pearlman M; Loomba R
Curr Opin Gastroenterol; 2014 May; 30(3):223-37. PubMed ID: 24717764
[TBL] [Abstract][Full Text] [Related]
12. Current treatment options for nonalcoholic fatty liver disease.
Shetty A; Syn WK
Curr Opin Gastroenterol; 2019 May; 35(3):168-176. PubMed ID: 30844893
[TBL] [Abstract][Full Text] [Related]
13. Nonalcoholic fatty liver disease: new treatments.
Hardy T; Anstee QM; Day CP
Curr Opin Gastroenterol; 2015 May; 31(3):175-83. PubMed ID: 25774446
[TBL] [Abstract][Full Text] [Related]
14. Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH.
Traussnigg S; Kienbacher C; Halilbasic E; Rechling C; Kazemi-Shirazi L; Hofer H; Munda P; Trauner M
Dig Dis; 2015; 33(4):598-607. PubMed ID: 26159280
[TBL] [Abstract][Full Text] [Related]
15. Meta-Analysis of Randomized Controlled Trials of Pharmacologic Agents in Non-alcoholic Steatohepatitis.
Said A; Akhter A
Ann Hepatol; 2017; 16(4):538-547. PubMed ID: 28611274
[TBL] [Abstract][Full Text] [Related]
16. Omega-3 polyunsaturated fatty acid and ursodeoxycholic acid have an additive effect in attenuating diet-induced nonalcoholic steatohepatitis in mice.
Kim JK; Lee KS; Lee DK; Lee SY; Chang HY; Choi J; Lee JI
Exp Mol Med; 2014 Dec; 46(12):e127. PubMed ID: 25523099
[TBL] [Abstract][Full Text] [Related]
17. Therapy for nonalcoholic fatty liver disease.
Moseley RH
J Clin Gastroenterol; 2008 Apr; 42(4):332-5. PubMed ID: 18277910
[No Abstract] [Full Text] [Related]
18. NASH Therapy: omega 3 supplementation, vitamin E, insulin sensitizers and statin drugs.
Caldwell S
Clin Mol Hepatol; 2017 Jun; 23(2):103-108. PubMed ID: 28494529
[TBL] [Abstract][Full Text] [Related]
19. Current and Potential Future Pharmacological Approaches for Non- Alcoholic Fatty Liver Disease.
Imprialos K; Stavropoulos K; Bouloukou S; Kerpiniotis G; Karagiannis A; Doumas M
Curr Vasc Pharmacol; 2018; 16(3):276-288. PubMed ID: 28676020
[TBL] [Abstract][Full Text] [Related]
20. Nonalcoholic fatty liver disease: pharmacologic and surgical options.
Parikh N; Ahmad J
Gastroenterol Clin North Am; 2011 Sep; 40(3):541-59. PubMed ID: 21893273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]